Marc Larochelle, MD, MPH
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, University of Pittsburgh School of Medicine
MPH, Harvard School of Public Health
BSE, Duke University



Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at BUSM. Larochelle's clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders. As a health services researcher, Larochelle aims to leverage insights from large data sources and translate the findings into interventions that improve the quality and value of health care delivered. His special interests are Primary Care and Addiction Medicine.

Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit



Records for Alcohol Care Enhancement (RACE)
09/20/2021 - 05/31/2022 (Multi-PI)
PI: Marc Larochelle, MD, MPH
NIH/National Institute on Alcohol Abuse and Alcoholism
4R33AA027597-03


Training in Health Services Research for Vulnerable Populations
07/01/2023 - 06/30/2024 (PI)
Agency for Healthcare Research and Quality/DHHS
2T32HS022242-11

MOUD Comparative Effectiveness Study
07/01/2021 - 04/30/2024 (PI)
National Institute on Drug Abuse/NIH/DHHS
1R01DA054268-01

Predict to Prevent: Dynamic Spatiotemporal Analyses of Opioid Overdose to Guide Pre-Emptive Public Health Responses
05/15/2022 - 03/31/2024 (PI)
Tufts University National Institute o
5R01DA054267-02

Improving urine drug test utility to mitigate prescription opioid risk
03/01/2020 - 02/28/2023 (PI)
National Institute on Drug Abuse/NIH/DHHS
5K23DA042168-03

Impact of health insurance type and transitions on treatment for opioid use disorder
04/01/2020 - 03/31/2022 (PI)
Robert Wood Johnson Foundation

Heroin use and overdose following changes to individual-level opioid prescribing
09/01/2017 - 08/31/2020 (PI)
University of Michigan National Center for
1U01CE002780-01


Title


Yr Title Project-Sub Proj Pubs
2023 Records for Alcohol Care Enhancement (RACE) 5R33AA027597-05
2023 MOUD Comparative Effectiveness Study 5R01DA054268-03
2023 Training in Health Services Research for Vulnerable Populations 2T32HS022242-11
2022 MOUD Comparative Effectiveness Study 5R01DA054268-02
2021 MOUD Comparative Effectiveness Study 1R01DA054268-01
2021 Improving urine drug test utility to mitigate prescription opioid risk 5K23DA042168-05 12
2020 Improving urine drug test utility to mitigate prescription opioid risk 5K23DA042168-04 12
2019 Improving urine drug test utility to mitigate prescription opioid risk 5K23DA042168-03 12
2018 Heroin use and overdose following changes to individual-level opioid prescribing 6U01CE002780-01M001 1
2018 Improving urine drug test utility to mitigate prescription opioid risk 5K23DA042168-02 12
Showing 10 of 12 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 Mar 22.View Related Profiles. PMID: 38519819
     
  2. Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Netw Open. 2024 Mar 04; 7(3):e242732.View Related Profiles. PMID: 38497959; PMCID: PMC10949092; DOI: 10.1001/jamanetworkopen.2024.2732;
     
  3. Bauer C, Hassan GH, Bayly R, Cordes J, Bernson D, Woods C, Li X, Li W, Ackerson LK, Larochelle MR, Stopka TJ. Trends in Fatal Opioid-Related Overdose in American Indian and Alaska Native Communities, 1999-2021. Am J Prev Med. 2024 Feb 03. PMID: 38311190
     
  4. McCann NC, LaRochelle MR, Morgan JR. Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort. J Subst Use Addict Treat. 2024 Apr; 159:209281.View Related Profiles. PMID: 38122988; PMCID: PMC10947919; DOI: 10.1016/j.josat.2023.209281;
     
  5. Tilhou AS, Murray E, Wang J, Linas BP, White L, Samet JH, LaRochelle M. Trends in buprenorphine dosage and days supplied for new treatment episodes for opioid use disorder, 2010-2019. Drug Alcohol Depend. 2023 Nov 01; 252:110981.View Related Profiles. PMID: 37839942; PMCID: PMC10615721; DOI: 10.1016/j.drugalcdep.2023.110981;
     
  6. Christine PJ, Larochelle MR, Lin LA, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023 Oct 06; 4(10):e233549. PMID: 37862034; PMCID: PMC10589810; DOI: 10.1001/jamahealthforum.2023.3549;
     
  7. Hammerslag LR, Mack A, Chandler RK, Fanucchi LC, Feaster DJ, LaRochelle MR, Lofwall MR, Nau M, Villani J, Walsh SL, Westgate PM, Slavova S, Talbert JC. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees. JAMA Netw Open. 2023 Oct 02; 6(10):e2336914. PMID: 37851446; PMCID: PMC10585416; DOI: 10.1001/jamanetworkopen.2023.36914;
     
  8. Pustz J, Srinivasan S, Shrestha S, Larochelle MR, Walley AY, Samet JH, Babakhanlou-Chase H, Carpenter JF, Stopka TJ. Applied risk mapping and spatial analysis of address-level decedent data to inform opioid overdose interventions: The Massachusetts HEALing Communities Study. Drug Alcohol Depend. 2023 Oct 01; 251:110947.View Related Profiles. PMID: 37666091; PMCID: PMC10587829; DOI: 10.1016/j.drugalcdep.2023.110947;
     
  9. Scherrer JF, Sullivan MD, LaRochelle MR, Grucza R. Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions. Addict Sci Clin Pract. 2023 Aug 17; 18(1):49. PMID: 37592369; PMCID: PMC10433556; DOI: 10.1186/s13722-023-00405-x;
     
  10. Chhatwal J, Mueller PP, Chen Q, Kulkarni N, Adee M, Zarkin G, LaRochelle MR, Knudsen AB, Barbosa C. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States. JAMA Netw Open. 2023 Jun 01; 6(6):e2314925. PMID: 37294571; PMCID: PMC10257094; DOI: 10.1001/jamanetworkopen.2023.14925;
     
Showing 10 of 96 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 96 publications over 13 distinct years, with a maximum of 17 publications in 2020

YearPublications
20041
20091
20142
20154
20163
20176
201812
201912
202017
202114
20229
202312
20243


Some Patients on Opioids Shouldn’t Have to Taper Off

Legal Reader 9/7/2022

Long-Term Opioid Tapering Does Not Benefit Suicide, Overdose Risks

HCP Live 8/15/2022

Opioid Overdose Deaths Rise Among Black Americans

Poz 9/28/2021

Opioid Overdose Death Rates Worsening for Non-Hispanic Blacks

Health Day 9/20/2021

Opioid Overdose Death Rates Are Rising Among Black Americans

Everyday Health 9/17/2021

How Overdose Surged for Black People as It Held Steady for Whites

Filter Magazine 9/15/2021

Researchers Call for Antiracist Approach to Address Disparities In Overdose Deaths

Verywell Health 9/15/2021

Fatal Opioid ODs Keep Rising in Black Americans

Health Day 9/13/2021

Fatal Opioid ODs Keep Rising in Black Americans

US News & World Report 9/13/2021

Disparities in Opioid Overdose Deaths Are Worsening for Black Americans

HealthCity 9/10/2021

Opioid Tapering Carries Significant Risks

MedPage Today 8/3/2021

Progress Against the Opioid Epidemic Is Not Reaching Black Americans

HealthCity 2/8/2021

Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study.

Physician's Weekly 8/27/2020

Let People Take Home Their Methadone

Gizmodo 4/1/2020

New Data Strongly Support Opioid Agonists for Addiction

Medscape 2/28/2020

Study Finds Less Than 2 Percent of Overdose Victims Had Active Opioid Prescriptions

Newsweek 10/22/2019

Opioid Stewardship Alone Misses Opportunities to Predict and Prevent Overdose Death: A Roadmap for Intervention

HealthCity 9/18/2019

Opioid overdose more likely if family member has prescription

Reuters 6/24/2019

Inpatient Opioids Influence At-Home Use

MedPage Today 6/17/2019

Letters to the Editor: Words Matter When it Comes to Addiction

CentralMaine.com 6/9/2019

More Opioid Addicts Turning to Vivitrol to Come Clean, Rebuild Their Lives

Newsday 4/13/2019

Opioid Prescriptions Drop Drastically In Ohio

The Fix 3/18/2019

Opioid Epidemic Will Get Worse, Researchers Says

The Fix 2/14/2019

Opioid Crisis to Increase in Upcoming Years

Specialty Pharmacy Times 2/8/2019

Cutting Down Prescription Opioid Supply May Not Stem The Crisis, Study Finds

WGBH 2/7/2019

Overdose Deaths Could Increase With ‘Changing Nature’ Of Opioid Epidemic

Penn State News 2/6/2019

Did you know that the opioid crisis is predicted to worsen?

Health Europa 2/4/2019

Limiting Opioid Prescriptions Will Do Little To Reduce Overdose Deaths, Study Says

The Boston Globe 2/1/2019

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Larochelle's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department